LRMR Larimar Therapeutics, Inc. - Common Stock
Larimar Therapeutics, Inc. - Common Stock 정보 위키백과 회사 개요
LRMR 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
LRMR 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
LRMR 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
- 적극 매수 8 47.1%
- 매수 8 47.1%
- 보유 1 5.9%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
10 명의 애널리스트 · 2026-08-18실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $-0.30 | $-0.39 | 0.09% |
| 2026년 3월 31일 | $-0.31 | $-0.55 | 0.24% |
| 2025년 12월 31일 | $-0.73 | $-0.52 | -0.21% |
| 2025년 9월 30일 | $-0.61 | $-0.41 | -0.20% |
| 2025년 6월 30일 | $-0.41 | $-0.49 | 0.08% |
| 2025년 3월 31일 | $-0.46 | $-0.43 | -0.03% |
| 2024년 12월 31일 | $-0.45 | $-0.32 | -0.13% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| LRMR | $317M | -2.2 | — | — | -167.4% | — |
| CABA | $220M | -1.0 | — | — | -115.5% | — |
| MPLT | $773M | -0.9 | — | — | -151.1% | — |
| QTTB | $43M | 1.4 | — | 55.5% | 200.3% | — |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | — |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | — |
| RZLT | $388M | -4.6 | — | — | -56.9% | — |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | — |
| BNTC | $307M | -11.1 | — | — | -43.8% | — |
| CAPR | $1.66B | -12.8 | -11.6% | — | -51.1% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 16
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $154M | $73M | $28M | $24M | $38M | $31M | $21M | $48M | $41M | $40M | $55M | $27M | |
| SG&A Expense | $18M | $18M | $14M | $12M | $12M | $11M | $2M | $13M | $12M | $18M | $19M | $8M | |
| Operating Expenses | $172M | $91M | $42M | $37M | $50M | $43M | $23M | $61M | $53M | $58M | $74M | $36M | |
| Operating Income | $-172M | $-91M | $-42M | $-37M | $-50M | $-43M | $-23M | $-61M | $-53M | $-58M | $-74M | $-36M | |
| Interest Expense | · | · | · | · | · | · | $2M | $2M | $165.0K | $529.0K | $806.0K | $870.0K | |
| Interest Income | · | · | · | · | · | · | $2M | $2M | $996.0K | · | · | · | |
| Other Non-op | $7M | $10M | $5M | $1M | $-171.0K | $322.0K | $82.0K | $-246.0K | $971.0K | $347.0K | $-473.0K | $-946.0K | |
| Pretax Income | $-166M | $-81M | $-37M | $-35M | $-51M | $-42M | $-23M | $-61M | $-52M | $-58M | $-74M | $-36M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-166M | $-81M | $-37M | $-35M | $-51M | $-42M | $-23M | $-61M | $-52M | $-58M | $-74M | $-36M | |
| EPS (Basic) | · | $-1.32 | $-0.84 | $-1.37 | $-2.95 | $-3.57 | · | · | · | · | · | · | |
| EPS (Diluted) | · | $-1.32 | $-0.84 | $-1.37 | $-2.95 | $-3.57 | · | · | · | · | · | · | |
| Shares (Basic) | · | 61,256,084 | 43,901,241 | 25,761,394 | 17,164,284 | 11,883,155 | · | · | · | · | · | · | |
| Shares (Diluted) | · | 61,256,084 | 43,901,241 | 25,761,394 | 17,164,284 | 11,883,155 | · | · | · | · | · | · | |
| EBITDA | $-172M | $-91M | $-42M | $-37M | $-50M | $-43M | $-46M | $-61M | $-53M | $-58M | · | $-36M |
대차대조표 23
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $33M | $27M | $27M | $70M | $68M | $1M | $49M | $41M | $32M | $36M | $58M | |
| Prepaid Expense | $5M | $12M | $3M | $2M | $2M | $5M | $4M | $2M | $2M | $1M | $2M | $1M | |
| Current Assets | $142M | $195M | $90M | $121M | $72M | $98M | $5M | $121M | $105M | $131M | $188M | $117M | |
| PP&E (Net) | $622.0K | $881.0K | $684.0K | $831.0K | $1M | $1M | $274.0K | $375.0K | $528.0K | $661.0K | $902.0K | $79.0K | |
| PP&E (Gross) | $3M | $2M | $2M | $2M | $2M | $1M | $453.0K | $925.0K | $1M | $981.0K | $1M | $129.0K | |
| Accum. Depreciation | $2M | $2M | $1M | $914.0K | $596.0K | $335.0K | $179.0K | $550.0K | $508.0K | $320.0K | $120.0K | $50.0K | |
| Other Non-current Assets | $523.0K | $596.0K | $659.0K | $638.0K | $669.0K | $419.0K | $90.0K | $57.0K | $57.0K | $61.0K | $94.0K | $242.0K | |
| Total Assets | $146M | $200M | $96M | $126M | $79M | $105M | $5M | $122M | $106M | $132M | $189M | $118M | |
| Accounts Payable | $5M | $2M | $1M | $2M | $2M | $3M | $4M | $4M | $3M | $3M | $7M | $2M | |
| Accrued Liabilities | $58M | $21M | $7M | $8M | $7M | $6M | $2M | $4M | $4M | $4M | $6M | $3M | |
| Short-term Debt | · | · | · | · | · | · | $7M | $5M | · | $4M | $3M | $1M | |
| Current Liabilities | $65M | $24M | $10M | $11M | $9M | $9M | $6M | $13M | $7M | $10M | $17M | $7M | |
| Capital Leases | $3M | $4M | $5M | $5M | $5M | $6M | $6M | · | · | · | · | · | |
| Total Liabilities | $68M | $28M | $14M | $16M | $14M | $15M | $6M | $28M | $27M | $10M | $20M | $13M | |
| Long-term Debt | · | · | · | · | · | · | $15M | $20M | $20M | $3M | · | · | |
| Total Debt | · | · | · | · | · | · | $7M | $5M | · | $4M | · | $1M | |
| Common Stock | $83.0K | $64.0K | $43.0K | $43.0K | $18.0K | $15.0K | $6.0K | $37.0K | $27.0K | $27.0K | $27.0K | $23.0K | |
| Paid-in Capital | $513M | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-435M | $-269M | $-189M | $-152M | $-116M | $-66M | $-23M | $-351M | $-290M | $-238M | $-180M | $-105M | |
| AOCI | $54.0K | $148.0K | $81.0K | $-31.0K | · | $1.0K | $35.0K | $-33.0K | $-58.0K | $-80.0K | $-207.0K | $-35.0K | |
| Stockholders' Equity | $78M | $172M | $82M | $111M | $64M | $90M | $-694.0K | $3M | $78M | $122M | $169M | $104M | |
| Liabilities + Equity | $146M | $200M | $96M | $126M | $79M | $105M | $5M | $122M | $106M | $132M | $189M | $118M | |
| Shares Outstanding | 83,090,392 | 63,815,065 | 43,909,069 | 43,269,200 | 17,710,450 | 15,367,730 | 6,091,250 | 37,287,221 | 27,489,457 | 27,332,551 | 27,242,503 | 22,879,160 |
현금 흐름 11
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $9M | $8M | $7M | $5M | $2M | $129.0K | $10M | $8M | $10M | $9M | $2M | |
| Restructuring | · | · | · | · | · | · | $6M | · | · | $1M | · | · | |
| Operating Cash Flow | $-113M | $-71M | $-33M | $-28M | $-42M | $-42M | $-23M | $-51M | $-44M | $-52M | $-60M | $-28M | |
| CapEx | $91.0K | $515.0K | $164.0K | $100.0K | $333.0K | $62.0K | $83.0K | $108.0K | $55.0K | $660.0K | $595.0K | $58.0K | |
| Investing Cash Flow | $100M | $-85M | $33M | $-91M | $24M | $17M | $-83.0K | $-7M | $36M | $51M | · | · | |
| Stock Issued | $65M | $162M | · | $75M | $20M | $76M | · | $65M | · | · | $130M | $103M | |
| Net Stock Activity | $65M | $162M | · | $75M | $20M | $76M | · | $65M | · | · | · | · | |
| Financing Cash Flow | $65M | $162M | $30.0K | $75M | $20M | $94M | $19M | $67M | $17M | $-3M | · | · | |
| Net Change in Cash | $52M | $6M | $-76.0K | $-43M | $2M | $68M | $-3M | $9M | $8M | $-3M | $-23M | $23M | |
| Free Cash Flow | $-113M | $-71M | $-34M | $-28M | $-42M | $-42M | $-42M | $-52M | $-44M | $-53M | · | $-28M | |
| Levered FCF | · | · | · | · | · | · | $-43M | $-53M | $-44M | $-53M | · | $-29M |
수익성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -95.8% | -54.4% | -33.2% | -34.5% | -55.2% | -77.3% | -44.9% | -54.0% | -43.9% | -36.1% | · | -46.9% | |
| ROE | -167.4% | -43.5% | -42.4% | -30.8% | -74.2% | -44.2% | -163.6% | -62.2% | -52.0% | -39.8% | · | -203.4% | |
| ROIC | -220.9% | -52.9% | -51.1% | -32.9% | -78.3% | -47.7% | -75.0% | -61.9% | -67.8% | -46.5% | · | -33.6% |
유동성 및 지급능력 4
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 8.0 | 9.5 | 11.3 | 8.2 | 10.9 | 5.9 | 9.1 | 14.4 | 13.2 | · | 17.0 | |
| Quick Ratio | 1.3 | 1.4 | 2.8 | 2.5 | 7.9 | 7.6 | 2.2 | 3.7 | 5.6 | 3.3 | · | 8.4 | |
| Debt / Equity | · | · | · | · | · | · | 0.1 | 0.1 | · | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | -25.9 | -32.2 | -321.2 | -110.1 | · | -40.8 |
효율성 1
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 |
가치 평가 (TTM) 12
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-166M | $-81M | $-37M | $-35M | $-51M | $-42M | $-23M | $-61M | $-52M | $-58M | $-74M | $-36M | |
| Market Cap | $317M | $247M | $200M | $179M | $191M | $329M | $499M | $2.21B | $1.52B | $1.04B | · | $8.47B | |
| Enterprise Value | · | · | · | · | · | · | $479M | $2.17B | · | $1.01B | · | $8.41B | |
| P/E | -2.2 | -2.9 | -5.4 | -3.0 | -3.7 | -6.0 | · | · | · | · | · | · | |
| P/B | 4.1 | 1.4 | 2.4 | 1.6 | 3.0 | 3.7 | 9.3 | 23.7 | 19.5 | 8.6 | · | 81.1 | |
| P / Tangible Book | 4.1 | 1.4 | 2.4 | 1.6 | 3.0 | 3.7 | · | · | · | · | · | · | |
| P / Cash Flow | -2.8 | -3.5 | -6.0 | -6.5 | -4.5 | -7.8 | -12.2 | -43.0 | -34.8 | -20.1 | · | -299.8 | |
| P / FCF | -2.8 | -3.5 | -5.9 | -6.5 | -4.5 | -7.8 | -12.0 | -42.9 | -34.8 | -19.8 | · | -299.2 | |
| EV / EBITDA | · | · | · | · | · | · | -10.5 | -35.5 | · | -17.4 | · | -236.7 | |
| EV / FCF | · | · | · | · | · | · | -11.5 | -42.1 | · | -19.3 | · | -297.2 | |
| Earnings Yield | -45.1% | -34.1% | -18.5% | -33.2% | -27.3% | -16.7% | · | · | · | · | · | · |
손익계산서 12
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $28M | $25M | $59M | $45M | $23M | $27M | $27M | $14M | $20M | $13M | $11M | $7M | $6M | $5M | $7M | $6M | |
| SG&A Expense | $6M | $6M | $5M | $5M | $4M | $5M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Operating Expenses | $34M | $31M | $64M | $49M | $28M | $31M | $31M | $18M | $25M | $17M | $14M | $10M | $10M | $8M | $10M | $9M | |
| Operating Income | $-34M | $-31M | $-64M | $-49M | $-28M | $-31M | $-31M | $-18M | $-25M | $-17M | $-14M | $-10M | $-10M | $-8M | $-10M | $-9M | |
| Other Non-op | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $193.0K | |
| Income Tax | · | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-33M | $-30M | $-62M | $-48M | $-26M | $-29M | $-29M | $-15M | $-22M | $-15M | $-13M | $-9M | $-8M | $-7M | $-9M | $-8M | |
| EPS (Basic) | · | · | · | $-0.61 | $-0.41 | $-0.46 | · | $-0.24 | $-0.34 | $-0.27 | $-0.29 | $-0.21 | $-0.19 | $-0.15 | $-0.04 | $-0.37 | |
| EPS (Diluted) | · | · | · | $-0.61 | $-0.41 | $-0.46 | · | $-0.24 | $-0.34 | $-0.27 | $-0.29 | $-0.21 | $-0.19 | $-0.15 | $-0.04 | $-0.37 | |
| Shares (Basic) | · | · | · | 78,324,767 | 64,027,892 | 63,964,008 | · | 63,806,158 | 63,801,792 | 53,553,707 | -87,797,703 | 43,903,738 | 43,897,603 | 43,897,603 | -33,144,540 | 22,228,228 | |
| Shares (Diluted) | · | · | · | 78,324,767 | 64,027,892 | 63,964,008 | · | 63,806,158 | 63,801,792 | 53,553,707 | -87,797,703 | 43,903,738 | 43,897,603 | 43,897,603 | -33,144,540 | 22,228,228 | |
| EBITDA | $-34M | $-31M | · | $-49M | $-28M | $-31M | · | $-18M | $-25M | $-17M | · | $-10M | $-10M | $-8M | · | $-9M |
대차대조표 20
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $93M | $178M | $85M | $90M | $21M | $21M | $33M | $35M | $32M | $110M | $27M | $39M | $94M | $112M | $27M | $86M | |
| Prepaid Expense | $4M | $5M | $5M | $8M | $7M | $8M | $12M | $10M | $5M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $161M | $205M | $142M | $183M | $146M | $165M | $195M | $213M | $231M | $231M | $90M | $98M | $106M | $113M | $121M | $127M | |
| PP&E (Net) | $639.0K | $558.0K | $622.0K | $709.0K | $797.0K | $855.0K | $881.0K | $779.0K | $844.0K | $604.0K | $684.0K | $601.0K | $677.0K | $753.0K | $831.0K | $909.0K | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $992.0K | $914.0K | $836.0K | |
| Other Non-current Assets | $480.0K | $504.0K | $523.0K | $542.0K | $561.0K | $582.0K | $596.0K | $621.0K | $636.0K | $678.0K | $659.0K | $634.0K | $644.0K | $632.0K | $638.0K | $643.0K | |
| Total Assets | $165M | $209M | $146M | $187M | $150M | $170M | $200M | $219M | $237M | $248M | $96M | $104M | $112M | $119M | $126M | $133M | |
| Accounts Payable | $8M | $9M | $5M | $11M | $4M | $2M | $2M | $2M | $3M | $2M | $1M | $756.0K | $2M | $695.0K | $2M | $849.0K | |
| Accrued Liabilities | $25M | $38M | $58M | $33M | $21M | $19M | $21M | $14M | $17M | $10M | $7M | $5M | $4M | $7M | $8M | $8M | |
| Current Liabilities | $34M | $48M | $65M | $45M | $27M | $22M | $24M | $16M | $21M | $13M | $10M | $7M | $7M | $8M | $11M | $9M | |
| Capital Leases | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Total Liabilities | $38M | $50M | $68M | $48M | $30M | $26M | $28M | $21M | $26M | $17M | $14M | $11M | $12M | $13M | $16M | $14M | |
| Common Stock | $103.0K | $103.0K | $83.0K | $86.0K | $64.0K | $64.0K | $64.0K | $64.0K | $64.0K | $64.0K | $43.0K | $43.0K | $43.0K | $43.0K | $43.0K | $43.0K | |
| Paid-in Capital | $625M | $622M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-497M | $-464M | $-435M | $-372M | $-325M | $-298M | $-269M | $-240M | $-225M | $-203M | $-189M | $-176M | $-166M | $-158M | $-152M | $-142M | |
| AOCI | $-12.0K | $6.0K | $54.0K | $66.0K | $-9.0K | $54.0K | $148.0K | $358.0K | $-150.0K | $-25.0K | $81.0K | $7.0K | $12.0K | · | $-31.0K | $-40.0K | |
| Stockholders' Equity | $127M | $158M | $78M | $139M | $120M | $144M | $172M | $198M | $211M | $231M | $82M | $93M | $100M | $106M | $111M | $119M | |
| Liabilities + Equity | $165M | $209M | $146M | $187M | $150M | $170M | $200M | $219M | $237M | $248M | $96M | $104M | $112M | $119M | $126M | $133M | |
| Shares Outstanding | 103,882,937 | 103,882,937 | 83,090,392 | 85,590,392 | 64,027,892 | 64,027,892 | 63,815,065 | 63,806,628 | 63,802,517 | 63,800,017 | 43,909,069 | 43,905,903 | 43,269,200 | 43,269,200 | 43,269,200 | 43,269,200 |
현금 흐름 8
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-44M | $-45M | · | · | $-19M | $-27M | $-22M | $-25M | $-14M | $-10M | $-9M | $-9M | $-7M | $-8M | $-7M | $-6M | |
| CapEx | · | · | $0 | $23.0K | $19.0K | $49.0K | $179.0K | $62.0K | · | · | · | · | · | · | $0 | $0 | |
| Investing Cash Flow | $-41M | $29M | · | · | $19M | $14M | $19M | $27M | $-63M | $-68M | $-3M | $-46M | $-10M | $92M | $-52M | $-3M | |
| Stock Issued | · | · | $-201.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-435.0K | $108M | · | · | · | · | $36.0K | $30.0K | $-334.0K | $162M | $0 | · | · | · | $-316.0K | · | |
| Net Change in Cash | $-85M | $93M | $-5M | $70M | $-539.0K | $-12M | $-3M | $3M | $-78M | $83M | $-12M | $-56M | $-17M | $85M | $-59M | $66M | |
| Free Cash Flow | · | · | · | · | · | $-27M | · | · | · | · | · | · | · | · | · | · |
수익성 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -20.8% | -15.6% | · | -23.5% | -13.5% | -14.0% | · | -9.6% | -12.4% | -8.0% | · | -7.6% | -9.6% | -6.9% | · | -7.5% | |
| ROE | -26.5% | -19.6% | · | -28.3% | -15.8% | -15.6% | · | -10.7% | -13.9% | -8.7% | · | -8.6% | -11.2% | -8.0% | · | -8.7% |
유동성 및 지급능력 2
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 4.3 | · | 4.1 | 5.5 | 7.5 | · | 13.1 | 10.9 | 18.0 | · | 15.0 | 14.6 | 14.2 | · | 13.5 | |
| Quick Ratio | 2.7 | 3.7 | · | 2.0 | 0.8 | 1.0 | · | 2.2 | 1.5 | 8.6 | · | 5.9 | 13.0 | 13.9 | · | 9.1 |
가치 평가 (TTM) 9
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-136M | $-133M | · | $-119M | $-93M | $-81M | · | $-61M | $-54M | $-39M | · | $-32M | $-32M | $-32M | · | $-43M | |
| Market Cap | $317M | $467M | · | $276M | $185M | $138M | · | $418M | $463M | $484M | · | $173M | $135M | $196M | · | $138M | |
| P/E | -1.8 | -2.6 | · | -1.9 | -2.0 | -1.6 | · | -6.2 | -7.2 | -9.3 | · | -4.3 | -2.7 | -3.1 | · | -1.4 | |
| P/B | 2.5 | 3.0 | · | 2.0 | 1.5 | 1.0 | · | 2.1 | 2.2 | 2.1 | · | 1.9 | 1.4 | 1.8 | · | 1.2 | |
| P / Tangible Book | 2.5 | 3.0 | · | 2.0 | 1.5 | 1.0 | · | 2.1 | 2.2 | 2.1 | · | 1.9 | 1.4 | 1.8 | · | 1.2 | |
| P / Cash Flow | · | -10.5 | · | · | · | -5.2 | · | · | · | -46.5 | · | · | · | -26.0 | · | · | |
| P / FCF | · | · | · | · | · | -5.2 | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -56.4% | -38.2% | · | -53.2% | -50.2% | -60.9% | · | -16.2% | -13.9% | -10.8% | · | -23.3% | -37.7% | -32.7% | · | -70.3% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 순이익 | $-166M | $-81M | $-37M | $-35M | $-51M |
| 희석 EPS | — | $-1.32 | $-0.84 | $-1.37 | $-2.95 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 2.2 | 8.0 | 9.5 | 11.3 | 8.2 |
| 당좌 비율 | 1.3 | 1.4 | 2.8 | 2.5 | 7.9 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-113M | $-71M | $-34M | $-28M | $-42M |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 179개의 제출자 · $259.1M 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 36 (-12 이전 분기 대비) | 29 (+15 이전 분기 대비) | 63 (+11 이전 분기 대비) | 43 (+1 이전 분기 대비) | +9.5M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. | $108,601,271 | 35,606,974 | 41.91% | 주식 |
| Blue Owl Capital Holdings LP | $27,947,629 | 9,163,157 | 10.79% | 주식 |
| Defilade Capital Management, L.P. | $11,193,912 | 3,670,135 | 4.32% | 주식 |
| Driehaus Capital Management LLC | $9,648,440 | 3,163,423 | 3.72% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $9,073,448 | 2,974,901 | 3.50% | 주식 |
| RTW INVESTMENTS, LP | $7,826,297 | 2,565,999 | 3.02% | 주식 |
| DAFNA Capital Management LLC | $6,124,900 | 2,008,164 | 2.36% | 주식 |
| GOLDMAN SACHS GROUP INC | $5,164,830 | 1,693,387 | 1.99% | 주식 |
| Qube Research & Technologies Ltd | $5,005,178 | 1,641,042 | 1.93% | 주식 |
| CITADEL ADVISORS LLC | $4,443,316 | 1,456,825 | 1.71% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $4,377,700 | 1,434,996 | 1.69% | 주식 |
| STATE STREET CORP | $4,306,002 | 1,411,804 | 1.66% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4,279,675 | 1,403,172 | 1.65% | 주식 |
| Woodline Partners LP | $4,272,593 | 1,400,850 | 1.65% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $4,065,763 | 1,333,037 | 1.57% | 주식 |
| FMR LLC | $2,858,750 | 937,295 | 1.10% | 주식 |
| SPHERA FUNDS MANAGEMENT LTD. | $2,824,312 | 926,004 | 1.09% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $2,730,479 | 895,239 | 1.05% | 주식 |
| Alyeska Investment Group, L.P. | $1,882,494 | 617,211 | 0.73% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,580,815 | 518,300 | 0.61% | 풋 옵션 |
| VANGUARD FIDUCIARY TRUST CO | $1,366,912 | 448,168 | 0.53% | 주식 |
| Fi3 FINANCIAL ADVISORS, LLC | $1,263,896 | 2,915 | 0.49% | 주식 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $1,218,604 | 399,542 | 0.47% | 주식 |
| MARSHALL WACE, LLP | $1,092,845 | 358,310 | 0.42% | 주식 |
| SummitTX Capital, L.P. | $1,074,466 | 352,284 | 0.41% | 주식 |
| Gem Investment Advisors, LLC | $974,533 | 319,519 | 0.38% | 주식 |
| Burkehill Global Management, LP | $915,000 | 300,000 | 0.35% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $907,201 | 297,443 | 0.35% | 주식 |
| HAP Trading, LLC | $848,766 | 262,776 | 0.33% | 주식 |
| ADAR1 Capital Management, LLC | $831,872 | 272,745 | 0.32% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $821,975 | 269,500 | 0.32% | 콜 옵션 |
| CITADEL ADVISORS LLC | $732,610 | 240,200 | 0.28% | 풋 옵션 |
| TWO SIGMA INVESTMENTS, LP | $720,206 | 236,133 | 0.28% | 주식 |
| Seven Fleet Capital Management LP | $704,309 | 230,921 | 0.27% | 주식 |
| HAP Trading, LLC | $687,173 | 237,776 | 0.27% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $631,255 | 206,969 | 0.24% | 주식 |
| IEQ CAPITAL, LLC | $620,258 | 203,363 | 0.24% | 주식 |
| Caption Management, LLC | $588,705 | 193,018 | 0.23% | 주식 |
| Soleus Capital Management, L.P. | $573,711 | 188,102 | 0.22% | 주식 |
| Cubist Systematic Strategies, LLC | $523,775 | 162,159 | 0.20% | 주식 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $520,254 | 170,575 | 0.20% | 주식 |
| Susquehanna Portfolio Strategies, LLC | $503,726 | 165,156 | 0.19% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $486,990 | 108,220 | 0.19% | 주식 |
| DIADEMA PARTNERS LP | $447,243 | 146,637 | 0.17% | 주식 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $440,505 | 144,428 | 0.17% | 주식 |
| UBS Group AG | $440,194 | 144,326 | 0.17% | 주식 |
| STATE OF WISCONSIN INVESTMENT BOARD | $421,498 | 138,196 | 0.16% | 주식 |
| Point72 Asset Management, L.P. | $411,158 | 134,806 | 0.16% | 주식 |
| Nuveen Asset Management, LLC | $366,137 | 94,609 | 0.14% | 주식 |
| Mariner, LLC | $349,099 | 114,445 | 0.13% | 주식 |
| Squarepoint Ops LLC | $346,096 | 113,474 | 0.13% | 주식 |
| Man Group plc | $344,799 | 113,049 | 0.13% | 주식 |
| TWO SIGMA ADVISERS, LP | $339,562 | 89,124 | 0.13% | 주식 |
| BlackRock, Inc. | $330,178 | 108,255 | 0.13% | 주식 |
| CWM, LLC | $288,567 | 64,126 | 0.11% | 주식 |
| ExodusPoint Capital Management, LP | $275,760 | 90,413 | 0.11% | 주식 |
| GOLDMAN SACHS GROUP INC | $274,500 | 90,000 | 0.11% | 콜 옵션 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $272,550 | 63,680 | 0.11% | 주식 |
| CARY STREET PARTNERS FINANCIAL LLC | $259,250 | 85,000 | 0.10% | 주식 |
| JANE STREET GROUP, LLC | $224,895 | 73,736 | 0.09% | 주식 |
| RHUMBLINE ADVISERS | $219,249 | 71,888 | 0.08% | 주식 |
| MERCER GLOBAL ADVISORS INC /ADV | $210,249 | 68,934 | 0.08% | 주식 |
| Quantbot Technologies LP | $209,752 | 68,771 | 0.08% | 주식 |
| Connor, Clark & Lunn Investment Management Ltd. | $182,353 | 59,788 | 0.07% | 주식 |
| CANADA PENSION PLAN INVESTMENT BOARD | $182,085 | 59,700 | 0.07% | 주식 |
| SIMPLEX TRADING, LLC | $178,754 | 58,608 | 0.07% | 주식 |
| XTX Topco Ltd | $168,387 | 55,209 | 0.06% | 주식 |
| CIBC WORLD MARKET INC. | $161,650 | 53,000 | 0.06% | 주식 |
| PRUDENTIAL FINANCIAL INC | $160,805 | 52,723 | 0.06% | 주식 |
| WINTON GROUP Ltd | $159,820 | 52,400 | 0.06% | 주식 |
| JOURNEY STRATEGIC WEALTH LLC | $158,670 | 35,260 | 0.06% | 주식 |
| FEDERATED HERMES, INC. | $152,579 | 50,026 | 0.06% | 주식 |
| BANK OF AMERICA CORP /DE/ | $145,190 | 47,603 | 0.06% | 주식 |
| Pale Fire Capital SE | $131,150 | 43,000 | 0.05% | 주식 |
| JPMORGAN CHASE & CO | $130,336 | 40,730 | 0.05% | 주식 |
| Next Level Private LLC | $127,185 | 41,700 | 0.05% | 주식 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $125,709 | 41,216 | 0.05% | 주식 |
| HAP Trading, LLC | $121,388 | 373,500 | 0.05% | 콜 옵션 |
| MetLife Investment Management, LLC | $121,384 | 39,798 | 0.05% | 주식 |
| HighTower Advisors, LLC | $114,979 | 37,698 | 0.04% | 주식 |
| Persistent Asset Partners Ltd | $113,991 | 37,374 | 0.04% | 주식 |
| DEUTSCHE BANK AG\ | $111,569 | 36,580 | 0.04% | 주식 |
| Velan Capital Investment Management LP | $100,650 | 33,000 | 0.04% | 주식 |
| CITIGROUP INC | $96,972 | 31,794 | 0.04% | 주식 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $93,489 | 30,652 | 0.04% | 주식 |
| Bank of New York Mellon Corp | $92,510 | 30,331 | 0.04% | 주식 |
| JANE STREET GROUP, LLC | $86,010 | 28,200 | 0.03% | 풋 옵션 |
| STRS OHIO | $80,825 | 26,500 | 0.03% | 주식 |
| AMERICAN CENTURY COMPANIES INC | $80,724 | 26,467 | 0.03% | 주식 |
| VANGUARD GROUP INC | $80,189 | 21,047 | 0.03% | 주식 |
| Invesco Ltd. | $79,669 | 26,121 | 0.03% | 주식 |
| CAPTRUST FINANCIAL ADVISORS | $76,894 | 25,211 | 0.03% | 주식 |
| Russell Investments Group, Ltd. | $76,756 | 25,166 | 0.03% | 주식 |
| COMMONWEALTH EQUITY SERVICES, LLC | $70,350 | 23,067 | 0.03% | 주식 |
| Cerity Partners LLC | $70,081 | 22,977 | 0.03% | 주식 |
| Engineers Gate Manager LP | $68,799 | 22,557 | 0.03% | 주식 |
| Cherry Tree Wealth Management, LLC | $68,688 | 15,264 | 0.03% | 주식 |
| Vanguard Global Advisers, LLC | $64,193 | 21,047 | 0.02% | 주식 |
| Walleye Trading LLC | $61,000 | 20,000 | 0.02% | 주식 |
| CITADEL ADVISORS LLC | $60,695 | 19,900 | 0.02% | 콜 옵션 |
회사 내부자 28 명의 내부자 · 12 임원 · 18 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Carole Ben-Maimon | President and CEO | 2026년 1월 26일 A | 368,276 | 0 | 0 | $0 |
| Jeffrey S. Hatfield | Chief Executive Officer | 2019년 1월 22일 A | — | 0 | 0 | $0 |
| Michael Celano | Chief Financial Officer | 2026년 1월 26일 A | 215,785 | 0 | 0 | $0 |
| Patricia L Allen | Chief Financial Officer | 2019년 1월 22일 A | 19,793 | 0 | 0 | $0 |
| Thomas E. Hughes | President and Chief Scientific Officer | 2018년 6월 28일 S | 125,247 | 0 | 0 | $0 |
| Patrick Loustau | President | 2016년 3월 31일 A | — | 0 | 0 | $0 |
| Gopi Shankar | Chief Development Officer | 2026년 1월 26일 A | 76,443 | 0 | 0 | $0 |
| Russell Clayton | Chief Medical Officer | 2026년 1월 26일 A | 71,443 | 0 | 0 | $0 |
| Singhal Priya | Head of Research & Development | 2019년 4월 2일 A | — | 0 | 0 | $0 |
| Brian Mcveigh | Chief Business Officer | 2019년 1월 22일 A | — | 0 | 0 | $0 |
| Dennis D Kim | Chief Medical Officer | 2019년 1월 22일 A | 21,443 | 0 | 0 | $0 |
| Alicia Secor | Chief Commercial Officer | 2016년 3월 31일 A | 0 | 0 | 0 | $0 |
| Thomas Edward Hamilton | 이사 | 2026년 7월 6일 P | 714,798 | 2 | 0 | $667,000 |
| Joseph Truitt | 이사 | 2026년 5월 19일 A | 2,750 | 0 | 0 | $0 |
| Frank E Thomas | 이사 | 2026년 5월 19일 A | 7,000 | 1 | 0 | $25,000 |
| Jeffrey W Sherman | 이사 | 2026년 5월 19일 A | 5,000 | 1 | 0 | $25,000 |
| Jonathan S Leff | 이사 | 2026년 5월 19일 A | — | 0 | 0 | $0 |
| Peter Barrett | 이사 | 2022년 5월 10일 A | 4,643,327 | 0 | 0 | $0 |
| Thomas O Daniel | 이사 | 2021년 5월 12일 A | 19,452 | 0 | 0 | $0 |
| Wendy Everett | 이사 | 2019년 6월 26일 A | — | 0 | 0 | $0 |
| Cameron Geoffrey Mcdonough | 이사 | 2019년 6월 26일 A | 0 | 0 | 0 | $0 |
| Robert J Perez | 이사 | 2019년 6월 26일 A | 5,322 | 0 | 0 | $0 |
| John L Lamattina | 이사 | 2019년 6월 26일 A | 31,376 | 0 | 0 | $0 |
| Bruce Booth | 이사 | 2018년 1월 3일 A | 4,638,028 | 0 | 0 | $0 |
| Frances K Heller | 이사 | 2017년 10월 13일 P | 47,961 | 0 | 0 | $0 |
| Kevin P Starr | 이사 | 2015년 9월 24일 J | 370,323 | 0 | 0 | $0 |
| Avi Y. Goldberg | 이사 | 2015년 9월 18일 S | 53,734 | 0 | 0 | $0 |
| CHONDRIAL THERAPEUTICS HOLDINGS, LLC | 10% 소유주 | 2020년 6월 26일 J | 8 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
행동주의자 및 5% 이상 소유자 3 보유
SEC 서류 13D를 제출한 투자자 — 발행인에 영향을 미치려는 의도로 5% 이상의 실질 소유권(행동주의 지분, 이사회 캠페인, M&A). 각 행은 해당 제출자의 포지션에 대한 가장 최근에 알려진 상태를 보여줍니다.
| 제출자 | 제출됨 | 지분 | 상태 | 목적 | 제출 |
|---|---|---|---|---|---|
| Deerfield Private Design Fund III, L.P., Deerfield Healthcare Innovations Fund, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Partners, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P., Deerfield Management Company, L.P., James E. Flynn ×12 제출 서류 | 2026년 3월 2일 | 34.41% | 수정본 | 수동적 투자 | SEC |
| Chondrial Therapeutics Holdings, LLC ×2 제출 서류 | 2020년 6월 30일 | — | 최초 제출 | — | SEC |
| Chondrial Therapeutics, Inc. | 2019년 12월 27일 | — | 최초 제출 | M&A / 매각 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF 보유 현황 29 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| IBRN · iShares Trust | 0.22% | 4,010 SH | 2026년 8월 8일 | 일간 |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.14% | 93,475 SH | 2026년 8월 8일 | 일간 |
| IWC · iShares Trust | 0.06% | 227,318 SH | 2026년 8월 8일 | 일간 |
| FSCC · Federated Hermes ETF Trust | 0.06% | 47,062 NS | 2026년 5월 31일 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.03% | 5,600 SH | 2026년 8월 8일 | 일간 |
| BIB · ProShares Trust | 0.02% | 4,014 NS | 2026년 5월 31일 | N-PORT |
| IWO · iShares Trust | 0.02% | 609,989 SH | 2026년 8월 8일 | 일간 |
| IBB · iShares Trust | 0.02% | 382,933 SH | 2026년 8월 8일 | 일간 |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 382,844 SH | 2026년 8월 8일 | 일간 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 71,780 SH | 2026년 8월 8일 | 일간 |
| DFAS · Dimensional ETF Trust | 0.01% | 316,227 NS | 2026년 4월 30일 | N-PORT |
| IWM · iShares Trust | 0.01% | 1,689,750 SH | 2026년 8월 8일 | 일간 |
| RSSL · Global X Funds | 0.01% | 20,396 NS | 2026년 4월 30일 | N-PORT |
| ITWO · ProShares Trust | 0.00% | 2,221 NS | 2026년 5월 31일 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0.00% | 24,913 NS | 2026년 5월 31일 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 12,923 NS | 2026년 4월 30일 | N-PORT |
| UWM · ProShares Trust | 0.00% | 1,737 NS | 2026년 5월 31일 | N-PORT |
| URTY · ProShares Trust | 0.00% | 1,755 NS | 2026년 5월 31일 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 6,906 NS | 2026년 4월 30일 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,788 NS | 2026년 5월 31일 | N-PORT |
| HDG · ProShares Trust | 0.00% | 44 NS | 2026년 5월 31일 | N-PORT |
| IWV · iShares Trust | 0.00% | 17,196 SH | 2026년 8월 8일 | 일간 |
| DFAU · Dimensional ETF Trust | 0.00% | 11,156 NS | 2026년 4월 30일 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 12,332 NS | 2026년 4월 30일 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 699,471 SH | 2026년 8월 8일 | 일간 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2,206,446 SH | 2026년 8월 8일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 7,400 SH | 2026년 8월 8일 | 일간 |
| DFUS · Dimensional ETF Trust | 0.00% | 1,156 NS | 2026년 4월 30일 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.00% | 172,125 SH | 2026년 8월 8일 | 일간 |